Fundraising Fox

Sofinnova Partners2016 Investments

3 investments dated 2016 · listed companies and verified rows first · show all

MaxcyteNASDAQ: MXCTMar 2016

BiotechGaithersburg, US

Douglas A Doerfler(Executive Officer, Director)Madhusudan V Peshwa(Executive Officer)Ronald E Holtz(Executive Officer, Director)Thomas Ross(Executive Officer)Arthur Mandell(Director)Sinclair Dunlop(Director)

Reflexionmedicalreflexion.comin𝕏Apr 2016

RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.

BiotechHealthtechMedical DevicesHayward, US

Samuel Mazin(Executive Officer, Director)Akshay Nanduri(Executive Officer, Director)

BoardJay Watkins(Director)

Board seatAntoine Papiernik Papiernik· per SEC Form D

Co-investorsAscension VenturesCatalio Capital Management, LPPfizer Venture InvestmentsSonder CapitalVenrockSonder Futures

Rgenixrgenix.comJun 2016SEC filingmedium confidence

BiotechNew York, US

Masoud Tavazoie(Chief Scientific Officer)David Darst(Chief Operating Officer)Isabel Kurth(Vice President - Research)

BoardShahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)

Board seatAntoine Papiernik Papiernik· per SEC Form D · $33M raise · filed Jun 2016

Co-investors+ND Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.